ZJYLNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends September 30
Jin Medical International Ltd.
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Feb 10, 2026
$2.11+0.03 (+1.44%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 10.5
- Dividend yield
- –
Jin Medical International Ltd. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Wheelchair [Member] | $16.22M | $14.87M | $16.35M | $15.62M | $18.21M | 78.4% | +9.1% |
| Other products [Member] | $2.58M | $6.75M | $702.93K | – | – | 12.5% | -61.8% |
| Wheelchair components [Member] | $1.89M | $1.88M | $2.77M | – | – | 9.1% | +0.2% |
| Wheelchair components and others [Member] | – | $8.64M | $3.47M | $3.57M | $2.56M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Overseas Market [Member] | $16.27M | $14.89M | $17.08M | $16.45M | $18.22M | 78.7% | +9.3% |
| China Domestic Market [Member] | $4.41M | $8.61M | $2.74M | $2.74M | $2.55M | 21.3% | -48.7% |
From the segment and revenue-disaggregation notes of Jin Medical International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.